KM
Kyle Moran
Chief Financial Officer

Kyle Moran insider trades: Wave Life Sciences (WVE) stock sales

Chief Financial Officer, Wave Life Sciences Last trade Feb 9, 2026 16 Form 4 filings
$4.2M
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2021
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Kyle reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 9, 2026WVE↓ Sell$48K
Dec 9, 2025WVE↓ Sell$4.1M
Sep 25, 2024WVE↓ Sell$154K
Apr 3, 2024WVE↓ Sell$96K
Aug 23, 2023WVE↓ Sell$176K
Feb 16, 2023WVE↓ Sell$39K
May 5, 2022WVE↓ Sell$9K
Feb 16, 2022WVE↓ Sell$21K
Feb 16, 2021WVE↓ Sell$18K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other WVE insiders

Open-market trades in the last 12 months

About Kyle Moran's insider trades

Kyle Moran is Chief Financial Officer at Wave Life Sciences (WVE). Since Feb 16, 2021, Kyle has reported no open-market purchases and 9 sales worth $4.7M on SEC Form 4. In the last 12 months: 2 sales ($4.2M).

Their filings also include grants and awards (10 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every WVE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.